About PsychoGenics
PsychoGenics is a Healthcare company based in Tarrytown (United States) founded in 1999. Preclinical CRO services for CNS and orphan disorders are offered. The company has 124 employees. Its website psychogenics.com draws about 13 thousand monthly visits. PsychoGenics offers products and services including eCube™, NeuroCube®, and Behavioral Testing. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include InVivo Biosystems, Noble Life Sciences and Alpha Genesis; 2 of its 3 listed competitors have raised funding.
Company details
Psychogenics offers drug discovery capabilities for companies focusing on CNS and orphan disorders psychiatric and neurodegenerative disorders, pain and inflammation, spinal cord and traumatic brain injury. PsychoGenics capabilities include behavioral testing, electrophysiology, molecular biology, microdialysis and a variety of in-licensed transgenic mouse models. PsychoGenics technologies have been developed to facilitate high throughput, in vivo, compound screening. It facilitates drug discovery by combining expertise in behavioral neurobiology, bioinformatics and behavioral testing platforms, that can rapidly screen compound libraries for CNS activity.
- Headquarters Tarrytown, United States
- Employees 124
- SectorsHealthcare
- Email••••••••
- Website psychogenics.com
- Social LinkedIn
- Latest Funding Round$3M (USD), Grant
Aug 2024
- InvestorsNIH
& 1 more
- Employee Count124
Products & Services of PsychoGenics
PsychoGenics offers a comprehensive portfolio of products and services, including eCube™, NeuroCube®, and Behavioral Testing.
AI tool for neuropsychiatric drug discovery and testing
Platform for analyzing neurological disorders in research
In vivo testing for efficacy in CNS disorder models
Funding Insights of PsychoGenics
- Total Rounds 6
- Last Round Grant — $3M
- First Round $1.35M
(Dec 2007)
- Investors Count 2
All 6 funding rounds of PsychoGenics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in PsychoGenics
PsychoGenics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for PsychoGenics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PsychoGenics
38 people are tracked at PsychoGenics (14 in leadership, 11 in board & advisors, 13 in team); the tracked headcount is 124.
| Name | Role | Group |
|---|---|---|
Herman B. Fernandes | Associate Director, Mouse Pharmacology & Electrophysiology | Leadership |
Dani Brunner | Chief Innovation Officer | Leadership |
Ronald E.D. Christopher | VP, Finance | Leadership |
Christina Leahy | VP, QA & Regulatory Affairs | Leadership |
Kathleen Kelly | VP, Human Resources | Leadership |
Emer Leahy | President & CEO | Leadership |
Mitchell Silverstein | VP, Facilities & Operations | Leadership |
Mark Varney | Chief Scientific Officer | Leadership |
Leslie Street | VP, Medicinal Chemistry | Leadership |
Stephen Morairty | VP, Translational Neuroscience | Leadership |
Kenneth Jones | Director, Vivarium Operations | Leadership |
Alberto Ambesi-Impiombato | Director, Computational Biology | Leadership |
Mark Urban | Director | Leadership |
Caroline Nagy | SR HR Business Partner | Leadership |
B. Lance Sauerteig | Director | Board & advisors |
Daniel Goodman | Director | Board & advisors |
Henry Jarecki | Chairman | Board & advisors |
John McCall | Scientific Advisor | Board & advisors |
Rene Hen | Scientific Advisor | Board & advisors |
Eric Nestler | Scientific Advisor | Board & advisors |
18 more people are available in the full profile.
Complete people profiles for PsychoGenics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PsychoGenics
3 dated milestones of PsychoGenics across 25 years, from founding to its latest funding, stage changes and deals.
- Founded PsychoGenics is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Grant, of $3.0M.
Competitors of PsychoGenics
PsychoGenics has 3 listed competitors in our database, 2 of them funded. They include InVivo Biosystems, Noble Life Sciences and Alpha Genesis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invivobiosystems.com | 2019 | United States | $8.16M | Animal models are supplied for in-vivo analytical services. | ||
| noblelifesci.com | 2010 | Woodbine, United States | $335,000 | Preclinical contract research organization offering standard GLP and non-GLP services | ||
| alphagenesisinc.com | 2003 | Yemassee, United States | 143 | Company offering primate models and services for preclinical drug discovery |
Detailed competitors of PsychoGenics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PsychoGenics
The website of PsychoGenics (psychogenics.com) receives about 13.2K visits a month.
- Monthly visits13.2K
▲ 63.8% vs previous month
Websites whose visitors overlap most with PsychoGenics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| criver.com | 100% | 224.6K | #186,811 | View details | |
| taconic.com | 99% | 49.8K | #707,498 | View details | |
jneurosci.org | jneurosci.org | 83% | #80,299 | – | |
 brainvat.wordpress.com | brainvat.wordpress.com | 79% | – | ||
| jax.org | 74% | 474.6K | #112,332 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for PsychoGenics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PsychoGenics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Psychogenics
Complete news archive for PsychoGenics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PsychoGenics
PsychoGenics was founded in 1999 and raised its 1st funding round 8 years after it was founded.
PsychoGenics is headquartered in Tarrytown, United States. It is registered at Tarrytown, New York, United States.
PsychoGenics has 124 employees.
Psychogenics offers drug discovery capabilities for companies focusing on CNS and orphan disorders psychiatric and neurodegenerative disorders, pain and inflammation, spinal cord and traumatic brain injury. PsychoGenics capabilities include behavioral testing, electrophysiology, molecular biology, microdialysis and a variety of in-licensed transgenic mouse models. PsychoGenics technologies have been developed to facilitate high throughput, in vivo, compound screening. It facilitates drug discovery by combining expertise in behavioral neurobiology, bioinformatics and behavioral testing platforms, that can rapidly screen compound libraries for CNS activity.
PsychoGenics's top competitors include Alpha Genesis, InVivo Biosystems and Noble Life Sciences.
PsychoGenics offers eCube™, NeuroCube®, and Behavioral Testing.